Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Aug 25;10(8):7174-7179.
doi: 10.19082/7174. eCollection 2018 Aug.

Thyrotoxic periodic paralysis: case report and review of the literature

Affiliations
Case Reports

Thyrotoxic periodic paralysis: case report and review of the literature

Vishnu Vardhan Garla et al. Electron Physician. .

Abstract

Introduction: Thyrotoxic periodic paralysis (TPP) is a rare and potentially lethal complication of hyperthyroidism. It is characterized by sudden onset paralysis associated with hypokalemia. Management includes prompt normalization of potassium, which results in resolution of the paralysis. Definitive treatment of hyperthyroidism resolves TPP completely.

Case presentation: A 23-year-old African American male patient presented to the emergency room at the University of Mississippi Medical Center, USA in November 2016 with sudden onset quadriplegia. He also endorsed a history of weight loss, palpitations, heat intolerance and tremors. The patient reported similar episodes of quadriplegia in the past, which were associated with hypokalemia and resolved with normalization of potassium levels. Physical examination was significant for exophthalmos, smooth goiter with bruit consistent with the diagnosis of Graves' disease. Laboratory assessment showed severe hypokalemia, hypomagnesemia, suppressed thyroid stimulating hormone (TSH) and high free thyroxine (T4). Urine potassium creatinine ratio was less than one, indicating transcellular shift as the cause of hypokalemia. After normalization of potassium and magnesium, the paralysis resolved in 12 hours. He was started on methimazole. On follow up, the patient was clinically and biochemically euthyroid with no further episodes of paralysis.

Take-away lesson: TPP is a rare and reversible cause of paralysis. Physicians need to be aware of the diagnostic and treatment modalities as delayed recognition in treatment could result in potential harm or unnecessary interventions.

Keywords: Graves’ disease; Hyperthyroidism; Hypokalemia; Periodic paralysis; Thyrotoxicosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: There is no conflict of interest to be declared.

Figures

Figure 1
Figure 1
Pathogenesis of Hypokalemia in Thyrotoxicosis.

References

    1. Okinaka S, Shizume K, Iino S, Watanabe A, Irie M, Noguchi A, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab. 1957;17(12):1454–9. doi: 10.1210/jcem-17-12-1454. - DOI - PubMed
    1. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of literature. Medicine. 1992;71(3):109–20. doi: 10.1097/00005792-199205000-00001. - DOI - PubMed
    1. Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006;91(7):2490–5. doi: 10.1210/jc.2006-0356. - DOI - PubMed
    1. Falhammar H, Thorén M, Calissendorff J. Thyrotoxic periodic paralysis: clinical and molecular aspects. Endocrine. 2013;43(2):274–84. - PubMed
    1. Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc. 2005;80(1):99–105. doi: 10.1016/S0025-6196(11)62965-0. - DOI - PubMed

Publication types

LinkOut - more resources